Erik Ostrowski - 02 Feb 2022 Form 4 Insider Report for AVROBIO, Inc. (TECX)

Role
Chief Financial Officer
Signature
/s/ Christopher Gerry, Attorney-in-Fact for Erik Ostrowski
Issuer symbol
TECX
Transactions as of
02 Feb 2022
Net transactions value
$0
Form type
4
Filing time
04 Feb 2022, 16:18:21 UTC
Previous filing
14 Jun 2021
Next filing
09 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVRO Stock Option (Right to Buy) Award $0 +170,000 $0.000000 170,000 02 Feb 2022 Common Stock 170,000 $1.84 Direct F1
transaction AVRO Stock Option (Right to Buy) Award $0 +145,000 $0.000000 145,000 02 Feb 2022 Common Stock 145,000 $1.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares shall vest and become exercisable on February 2, 2023, and the remaining 75% shall vest in equal monthly installments thereafter over a 3 year period.